Discover investment opportunities in Top 30 Stocks Under $13 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $13 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $13 using our Smart AI Filter.
5 stocks found for "Top 30 Stocks Under $13"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.17 Risk measure | ±100.0% Price volatility | -4.1 Valuation | 0.00% Annual yield | |||
0.09 Risk measure | ±52.5% Price volatility | -52.4 Valuation | 0.00% Annual yield | |||
0.42 Risk measure | ±21.7% Price volatility | 6.9 Valuation | 12.99% Annual yield | |||
1.05 Risk measure | ±45.9% Price volatility | 9.6 Valuation | 3.09% Annual yield | |||
0.79 Risk measure | ±66.3% Price volatility | -11.4 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
atai Life Sciences (ATAI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Read moreAmid a surge in research targeting cognitive disorders, the pharmaceutical industry is witnessing a wave of pivotal trial results that could reshape schizophrenia treatment paradigms. As biotech firms race to develop innovative therapies, Recognify Life Sciences steps into the spotlight with new findings from its latest clinical trial.
Read moreQ: What sets ARTL apart from other biotech stocks in the under $13 category?
A: Artelo Biosciences (ARTL) specializes in ethical cannabinoid-based medicines. The company's focus on synthesizing effective drug candidates for high-need conditions could differentiate it from other biotech firms. Investors might find its novel approach appealing despite typical sector volatility.
Q: Why might some investors consider ATAI a growth opportunity in mental health?
A: ATAI Life Sciences is engaged in developing psychedelic therapies for mental health issues, a sector with rising demand. Its partnerships with innovative companies underline potential growth. However, the high-risk nature of biotech should be evaluated carefully.
Q: What makes HURA an attractive option for sustainable investing enthusiasts?
A: Horizons Global Uranium Index ETF (HURA) focuses on uranium-related investments, crucial for nuclear energy, a low-carbon power source. The ETF appeals to investors interested in sustainable energy, despite market volatility linked to commodity prices.
Q: How might economic cycles impact SERV's stock performance?
A: ServiceMaster (SERV) operates in essential services like pest control and home warranties. Such sectors often exhibit stability, offering some resilience during economic downturns, though growth may be limited in booms compared to cyclical industries.
Q: Does ZSPC offer competitive advantages in the tech sector?
A: Despite being a smaller tech player, ZSPC (Zynex) focuses on innovative medical devices, potentially capitalizing on the aging population trend. Competition from larger firms is a risk, but specialization offers niche advantages.
Q: What income potential does WTTR offer its investors?
A: Select Water Solutions (WTTR) operates in the water management sector for the oilfield market. Although known for providing essential services, its income potential is closely tied to energy sector health, influencing dividend reliability and stability.